<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04138017</url>
  </required_header>
  <id_info>
    <org_study_id>20532</org_study_id>
    <nct_id>NCT04138017</nct_id>
  </id_info>
  <brief_title>ViviGen Cellular Bone Matrix for Hindfoot or Ankle Arthrodesis</brief_title>
  <acronym>ViviGen</acronym>
  <official_title>Clinical and Radiographic Outcomes Using ViviGenÂ® Cellular Bone Matrix for Complex Hindfoot Arthrodesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DePuy Synthes</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the fusion status of the hindfoot bones after receiving the ViviGen graft, an FDA&#xD;
      approved cellular bone matrix. This is used in a population indicated for hindfoot&#xD;
      arthrodesis as an alternative to an autograft.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date type="Actual">October 23, 2018</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion</measure>
    <time_frame>12 months</time_frame>
    <description>Radiographic evidence of successful arthrodesis confirmed on Computed Tomography (CT) scan defined by &gt;50%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Failure of hardware or obvious non-union</measure>
    <time_frame>12 months</time_frame>
    <description>Failure measured through clinical and radiographic evidence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foot and Ankle Ability Measure (FAAM)</measure>
    <time_frame>12 months</time_frame>
    <description>Patient reported outcome measurement that includes 29-item questionnaire divided into two subscales: 21-item activities of daily living subscale and 8-item sports subscale. Response options are given in 5 point Likert scales (range from 4-0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D levels</measure>
    <time_frame>6 months</time_frame>
    <description>25-Hydroxyvitamin D2 and D3 Blood test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Pain Scale</measure>
    <time_frame>12 months</time_frame>
    <description>Patient Foot pain reported on a 10 Centimeter line. Patient is asked to draw a vertical line where they believe their pain falls at rest and when active. This is on a scale of 0-10 with 0 being no pain and 10 being the most pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>American Orthopaedic Foot and Ankle Society(AOFAS) hindfoot score</measure>
    <time_frame>12 months</time_frame>
    <description>Patient reported outcome for a standardized evaluation of clinical status of ankle- hindfoot. Patient reports their pain and the physician records physical assessment of alignment. Finally function is reported and the AOFAS score ranged from 0-100 with 100 being healthy ankles.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VR-12 (Veterans RAND 12)</measure>
    <time_frame>12 months</time_frame>
    <description>Patient reported outcome for health related quality of life using a 12 item questionnaire. This is broken into two scores: Physical Health component scores, and Mental Health component scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System Physical Function-Short Form 8b (PROMIS Item Bank v2.0-Physical Function -Short Form 8b)</measure>
    <time_frame>12 months</time_frame>
    <description>Patient self-reported capability for physical function using 8 questions to assess current function of an adult in the general population.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Ankle Deformity</condition>
  <condition>Ankle Arthritis</condition>
  <arm_group>
    <arm_group_label>ViviGen Cellular Bone Matrix</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive the vivigen cellular bone matrix</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ViviGen</intervention_name>
    <description>A cellular bone matrix which includes viable osteoblasts within a corticocancellous and demineralized bone carrier, represents a unique alternative to autograft or existing products which utilize mesenchymal stem cells.</description>
    <arm_group_label>ViviGen Cellular Bone Matrix</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with prescribed standard of care unilateral hindfoot ankle arthrodesis&#xD;
             procedure&#xD;
&#xD;
          -  Age 18-80&#xD;
&#xD;
          -  Willing to complete all follow up evaluations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior infection at site of planned arthrodesis&#xD;
&#xD;
          -  Prior arthrodesis procedure&#xD;
&#xD;
          -  Inability to maintain non-weight bearing status&#xD;
&#xD;
          -  Bone defect requiring more than 10 cc of bone graft material&#xD;
&#xD;
          -  Known Vitamin D deficiency with a Vitamin D level of &lt;30ng/ml 1 week prior to surgery&#xD;
&#xD;
          -  Inadequate bone stock to allow for rigid internal fixation&#xD;
&#xD;
          -  Hemoglobin A1C greater than 8.0%&#xD;
&#xD;
          -  Tobacco or Nicotine use 6 weeks prior to surgery&#xD;
&#xD;
          -  BMI greater than 40&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>January 2, 2019</study_first_submitted>
  <study_first_submitted_qc>October 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2019</study_first_posted>
  <last_update_submitted>October 22, 2019</last_update_submitted>
  <last_update_submitted_qc>October 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthrodesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

